Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in Its ARTISTRY-1 Clinical Trial of Nemvaleukin, Its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer

GlobeNewswire05:15

Express News | Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in Its Artistry-1 Clinical Trial of Nemvaleukin, Its Lead Engineered Fusion Protein, in the Journal for Immunotherapy of Cancer

Breakings05:15

Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13

Futu NewsNov 14 20:31 · Ratings

Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX), Mural Oncology Plc (MURA) and Copa Holdings (CPA)

TipRanksNov 14 20:00 · Ratings

Express News | Mural Oncology PLC Files for Mixed Shelf Offering of up to $300 Mln- SEC Filing

BreakingsNov 14 05:08

H.C. Wainwright Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $18

Futu NewsNov 14 01:31 · Ratings